Bruno JE, Herne CA, Baran AM, VanDerMeid KR, et al. Treatment of Relapsed/Refractory CLL Patients With PI3Kdelta Inhibitor and Anti-CD20 Antibody Rapidly Decreases Tumor Burden but Could Induce Resistance. Am J Hematol 2025;100:523-526.
PMID: 39745891